CY1110939T1 - Μεθοδος κατασκευης μιας ανασυνδυασμενης πολυκλωνης πρωτεινης - Google Patents

Μεθοδος κατασκευης μιας ανασυνδυασμενης πολυκλωνης πρωτεινης

Info

Publication number
CY1110939T1
CY1110939T1 CY20101101058T CY101101058T CY1110939T1 CY 1110939 T1 CY1110939 T1 CY 1110939T1 CY 20101101058 T CY20101101058 T CY 20101101058T CY 101101058 T CY101101058 T CY 101101058T CY 1110939 T1 CY1110939 T1 CY 1110939T1
Authority
CY
Cyprus
Prior art keywords
collection
cells
recovered
construction
protein
Prior art date
Application number
CY20101101058T
Other languages
Greek (el)
English (en)
Inventor
Lars Soegaard Nielsen
Dietmar Weilguny
Anne Bondgaard Tolstrup
Finn Wiberg
Christian Müller
Original Assignee
Symphogen A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symphogen A/S filed Critical Symphogen A/S
Publication of CY1110939T1 publication Critical patent/CY1110939T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1086—Preparation or screening of expression libraries, e.g. reporter assays
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Non-Volatile Memory (AREA)
CY20101101058T 2007-05-25 2010-11-24 Μεθοδος κατασκευης μιας ανασυνδυασμενης πολυκλωνης πρωτεινης CY1110939T1 (el)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DKPA200700764 2007-05-25
US92470807P 2007-05-29 2007-05-29
DKPA200701292 2007-09-07
US96000207P 2007-09-11 2007-09-11
EP08748815A EP2152872B1 (en) 2007-05-25 2008-05-21 Method for manufacturing a recombinant polyclonal protein

Publications (1)

Publication Number Publication Date
CY1110939T1 true CY1110939T1 (el) 2015-06-10

Family

ID=39739965

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20101101058T CY1110939T1 (el) 2007-05-25 2010-11-24 Μεθοδος κατασκευης μιας ανασυνδυασμενης πολυκλωνης πρωτεινης

Country Status (22)

Country Link
US (1) US7910332B2 (enExample)
EP (1) EP2152872B1 (enExample)
JP (2) JP5941616B2 (enExample)
KR (1) KR101555658B1 (enExample)
CN (1) CN101688204B (enExample)
AT (1) ATE481483T1 (enExample)
AU (1) AU2008255383B2 (enExample)
BR (1) BRPI0812091A2 (enExample)
CA (1) CA2683800C (enExample)
CY (1) CY1110939T1 (enExample)
DE (1) DE602008002593D1 (enExample)
DK (1) DK2152872T3 (enExample)
HR (1) HRP20100640T1 (enExample)
IL (1) IL201395A (enExample)
MX (1) MX2009012526A (enExample)
NZ (1) NZ581316A (enExample)
PL (1) PL2152872T3 (enExample)
PT (1) PT2152872E (enExample)
SI (1) SI2152872T1 (enExample)
TW (1) TW200902548A (enExample)
WO (1) WO2008145133A2 (enExample)
ZA (1) ZA200908021B (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2512647C (en) 2003-01-07 2013-10-08 Symphogen A/S Method for manufacturing recombinant polyclonal proteins
MX2009008908A (es) * 2007-03-01 2009-08-28 Symphogen As Metodo para clonacion de anticuerpos analogos.
NZ581316A (en) * 2007-05-25 2012-02-24 Symphogen As Method for manufacturing a recombinant polyclonal protein
CN101821289A (zh) * 2007-09-07 2010-09-01 西福根有限公司 重组制造抗rsv抗体的方法
CA2713885A1 (en) * 2008-02-01 2009-08-20 Chromocell Corporation Novel cell lines and methods
EP2098536A1 (en) 2008-03-05 2009-09-09 4-Antibody AG Isolation and identification of antigen- or ligand-specific binding proteins
BRPI0910454A2 (pt) * 2008-04-23 2018-03-27 Symphogen As processo para produção de uma proteína policlonal
EP2297331B1 (en) * 2008-05-28 2015-03-25 Bayer HealthCare, LLC Methods and compositions for production of recombinant protein in hbx-expressing mammalian cells
MX2011001930A (es) * 2008-08-29 2011-04-21 Symphogen As Metodo para clonar anticuerpos derivados de aves.
DK2393927T3 (en) 2009-02-09 2015-03-30 Morphosys Ag Preparation of oligoclonal mixtures of antibodies in the individual cells
ES2692379T3 (es) 2010-11-01 2018-12-03 Symphogen A/S Anticuerpos anti-HER3 y composiciones
CA2817751C (en) 2010-11-16 2019-04-30 Excelimmune, Inc. Methods for producing recombinant proteins
CN102558353A (zh) * 2011-12-09 2012-07-11 上海应用技术学院 一种大肠杆菌NrfA基因表达蛋白多克隆抗体及其制备方法
GB2502127A (en) 2012-05-17 2013-11-20 Kymab Ltd Multivalent antibodies and in vivo methods for their production
WO2013164689A2 (en) 2012-05-02 2013-11-07 Lantto, Johan Humanized pan-her antibody compositions
JP2016514091A (ja) 2013-02-08 2016-05-19 ミスフォールディング ダイアグノスティクス， インコーポレイテッド トランスサイレチン抗体およびその使用
WO2016042412A1 (en) 2014-09-16 2016-03-24 Symphogen A/S Anti-met antibodies and compositions
US12404552B2 (en) * 2015-07-17 2025-09-02 Allele Biotechnology & Pharmaceuticals, Inc. Methods of selecting antibodies and antibody fragments
JP2019501658A (ja) * 2016-01-14 2019-01-24 アントン バウアーＡｎｔｏｎ Ｂａｕｅｒ 生産用細胞株を作製する方法
WO2018073393A2 (en) 2016-10-19 2018-04-26 Cellectis Tal-effector nuclease (talen) -modified allogenic cells suitable for therapy
CN110621698B (zh) 2017-04-05 2024-04-12 法国施维雅药厂 靶向pd-1、tim-3及lag-3的组合疗法
MA52945A (fr) 2018-06-22 2021-04-28 Genmab As Procédé de production d'un mélange contrôlé d'au moins deux anticorps différents
CA3118692A1 (en) 2018-11-06 2020-05-14 Alsatech, Inc. Cell-based gene therapy for neurodegenerative diseases
CN109988751A (zh) * 2019-01-15 2019-07-09 济宁学院 一种用于制备抗egfr全人源化单克隆抗体的细胞株构建方法
AU2020264492A1 (en) * 2019-04-30 2021-10-14 Gigagen, Inc. Recombinant polyclonal proteins and methods of use thereof
WO2021058709A1 (en) * 2019-09-27 2021-04-01 Glaxosmithkline Intellectual Property Development Limited Method of predicting production stability of clonal cell lines
CA3177152A1 (en) 2020-06-12 2021-12-16 David Scott Johnson Recombinant polyclonal proteins targeting covid-19 and methods of use thereof
WO2024240634A1 (en) 2023-05-19 2024-11-28 Les Laboratoires Servier Anti-met antibodies, antibody-drug conjugates, compositions and uses thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991016074A1 (en) 1990-04-19 1991-10-31 Medimmune, Inc. Administration of monoclonal antibodies against respiratory viruses
GB9022543D0 (en) * 1990-10-17 1990-11-28 Wellcome Found Antibody production
US6111166A (en) 1994-09-19 2000-08-29 Medarex, Incorporated Transgenic mice expressing human Fcα and β receptors
GB9703369D0 (en) 1997-02-18 1997-04-09 Lindqvist Bjorn H Process
WO2001094571A1 (fr) * 2000-06-08 2001-12-13 Mitsubishi Pharma Corporation Vecteur d'expression permettant le criblage de cellules a haute expression de proteine de recombinaison, transformant a haute expression de proteine de recombinaison, et leur utilisation
US6849259B2 (en) 2000-06-16 2005-02-01 Symphogen A/S Polyclonal antibody composition for treating allergy
SI1523496T1 (sl) * 2002-07-18 2011-11-30 Merus B V Rekombinantno proizvajanje zmesi protiteles
US20040115814A1 (en) * 2002-09-30 2004-06-17 Protein Design Labs, Inc. Efficient generation of stable expression cell lines through the use of scorable homeostatic reporter genes
CN100383244C (zh) * 2003-01-07 2008-04-23 西福根有限公司 用于生产重组多克隆蛋白质的方法
CA2512647C (en) * 2003-01-07 2013-10-08 Symphogen A/S Method for manufacturing recombinant polyclonal proteins
US20060275766A1 (en) 2003-01-07 2006-12-07 Haurum John S Method for manufacturing recombinant polyclonal proteins
TWI333977B (en) * 2003-09-18 2010-12-01 Symphogen As Method for linking sequences of interest
BRPI0513706A (pt) * 2004-07-20 2008-05-13 Symphogen As anticorpo policlonal recombinante anti-rhesus d e métodos de produção
RU2426795C2 (ru) * 2004-07-20 2011-08-20 Симфоген А/С Способ структурной характеристики рекомбинантного поликлонального белка или поликлональной клеточной линии
JP2009518320A (ja) 2005-12-05 2009-05-07 シュムフォウエン アクティーゼルスカブ 抗オルトポックスウイルス組換えポリクローナル抗体
KR20080113223A (ko) 2006-03-06 2008-12-29 심포젠 에이/에스 호흡기세포 융합 바이러스 감염 치료용 재조합 폴리클로날 항체
NZ581316A (en) * 2007-05-25 2012-02-24 Symphogen As Method for manufacturing a recombinant polyclonal protein

Also Published As

Publication number Publication date
AU2008255383B2 (en) 2012-11-01
BRPI0812091A2 (pt) 2014-10-14
JP2011504721A (ja) 2011-02-17
WO2008145133A3 (en) 2009-02-05
DE602008002593D1 (de) 2010-10-28
CA2683800A1 (en) 2008-12-04
PT2152872E (pt) 2010-11-17
WO2008145133A2 (en) 2008-12-04
US20090111142A1 (en) 2009-04-30
MX2009012526A (es) 2009-12-09
NZ581316A (en) 2012-02-24
CN101688204B (zh) 2013-07-03
ZA200908021B (en) 2010-11-24
TW200902548A (en) 2009-01-16
CN101688204A (zh) 2010-03-31
HK1134519A1 (en) 2010-04-30
EP2152872A2 (en) 2010-02-17
JP2015037411A (ja) 2015-02-26
PL2152872T3 (pl) 2011-03-31
ATE481483T1 (de) 2010-10-15
JP5941616B2 (ja) 2016-06-29
SI2152872T1 (sl) 2011-01-31
IL201395A (en) 2015-09-24
DK2152872T3 (da) 2010-12-06
KR20100017923A (ko) 2010-02-16
US7910332B2 (en) 2011-03-22
EP2152872B1 (en) 2010-09-15
KR101555658B1 (ko) 2015-09-24
AU2008255383A1 (en) 2008-12-04
CA2683800C (en) 2015-03-17
HRP20100640T1 (hr) 2010-12-31
IL201395A0 (en) 2011-08-01

Similar Documents

Publication Publication Date Title
CY1110939T1 (el) Μεθοδος κατασκευης μιας ανασυνδυασμενης πολυκλωνης πρωτεινης
MX2010002044A (es) Metodos para produccion recombinante de anticuerpos anti-virus sincitial respiratorio (anti-rsv).
WO2004061104A3 (en) Method for manufacturing recombinant polyclonal proteins
PH12020551039A1 (en) Non-viral dna vectors and uses thereof for antibody and fusion protein production
EA201492202A1 (ru) Способ экспрессии гетерологичных белков с использованием рекомбинантного вирусного вектора с минус-нитью рнк
MX2010008099A (es) Anticuerpos y angiopoyetina-2 estabilizados y sus usos.
BRPI0516572A (pt) métodos e composições para melhorar a produção de proteìnas recombinantes
MX2010007729A (es) Vectores de expresion de mamifero mejorados y uso de los mismos.
EA200700249A1 (ru) Рекомбинантное поликлональное антитело против резус-фактора d и способы его получения
EP2534257A4 (en) METHOD OF IDENTIFYING AND ISOLATING CELLS FOR THE EXPRESSION OF POLYPEPTIDES
MX2024003355A (es) Anticuerpos anti-cd3.
EA201001762A1 (ru) Антитела и способы их получения
CY1114463T1 (el) Κλωνος κυτταρου που παραγει fsh
WO2007130543A3 (en) Method for producing stable mammalian cell lines producing high levels of recombinant proteins
MX2025004565A (es) Anticuerpos anti-cd3 dependientes de ph y metodos relacionados con estos
RU2014129729A (ru) Строение экспрессионного вектора, новые способы получения клеток-продуцентов и их применение для рекомбинантного получения полипептидов
WO2004111194A3 (en) Method to increase protein production in culture
ATE469917T2 (de) Verfahren zur gewinnung von antikörpern
BR112013024781A2 (pt) método de produção de polipeptídeo recombinante
EA200700942A1 (ru) Способ определения качества клеточной культуры
ATE476449T1 (de) Verwendung von endosialinbindenden proteinen zum isolieren endosialinpositiver zellen
HK1138860A (en) Methods for recombinant manufacturing of anti-rsv antibodies
WO2008127486A3 (en) Replication-proficient dsrna capsids and uses thereof
AU2016216577A1 (en) Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells
MX2024003411A (es) Métodos para controlar la heterogeneidad de anticuerpos.